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ThisstudyinvestigatedtherelationshipbetweenantiapoptoticactivitiesinducedbyactivatedproteinCandendoplasmicreticulum
stress. In this study, it was observed that activated protein C elicited a rise in glucose-regulated protein 78 and glycogen synthase
kinase-3β andinhibitedapoptosisinhumanumbilicalveinendothelialcellsinducedbylipopolysaccharide.Calciuminhibitiondid
not alter the antiapoptotic eﬀect of activated protein C. The antiapoptotic eﬃciency of activated protein C was reduced in human
umbilical vein endothelial cells following treatment with glycogen synthase kinase-3β- s i R N A .I ns u m m a r y ,a c t i v a t e dp r o t e i nC
induced endoplasmic reticulum stress and attenuated lipopolysaccharide-induced human umbilical vein endothelial cell apoptosis
mediated by glycogen synthase kinase-3β.
1.Introduction
Activated protein C (APC), a vitamin-K-dependent serine
protease,playsanessentialroleinbloodcoagulationtogether
with its cofactor, protein S [1–3]. In recent years, many
studies have provided clinical evidence of improved out-
comes in severe sepsis following treatment with recombinant
APC treatment [4, 5]. It is a pharmacologic success, and in-
ternational guidelines have recommended the inclusion of
recombinant APC in the management of severe sepsis [6, 7].
However,theunderlyingmechanismthiseﬀectremainstobe
elucidated.
APC exhibits pleiotropic characteristics in addition to
its anticoagulant properties of APC [1–3], including anti-
inﬂammatory activities, antiapoptotic activity, and protec-
tion of endothelial barrier function [8, 9]. Several studies
have shown that the mitochondrion is the main site of the
antiapoptotic activity of APC [9]. However, the involvement
of APC in the induction of endoplasmic reticulum (ER)
stress and inhibition of apoptosis has not been determined.
Therefore, this study aimed to investigate the relationship
between antiapoptotic activities induced by APC and ER
stress in order to elucidate the mechanism of the cytopro-
tective eﬀects of APC.
ERisthesiteofsynthesis,folding,maturation,andtrans-
portofunfoldedproteins[10,11].ERstressincreasesunfold-
ed protein load and causes destabilization of cellular calcium
[10–13]. To reduce the accumulation of misfolded proteins
in the ER, the unfolded protein response (UPR), an adaptive
response, promotes and reestablishes ER homeostasis and
increases ER folding capacity. Glucose-regulated protein
78 (GRP78), a classic molecular chaperone, interacts with
exposed hydrophobic areas of protein-folding intermedi-
ates and is responsible for maintaining the protein in2 Mediators of Inﬂammation
a folding-competent state [10–13]. To overcome the destabi-
lization of cellular calcium, calcium ﬂux from the ER to the
mitochondria or cytoplasma maintains ER calcium home-
ostasis [13]. Furthermore, ER stress induces an antiapoptotic
eﬀect via a pathway involving glycogen synthase kinase-3β
(GSK-3β)[ 14].
There is evidence that APC treatment modulates gene
expression in endothelial cells (ECs) [9], which increase the
workload of the ER. Moreover, APC may induce calcium
release from the ER in human brain ECs and human um-
bilical vein endothelial cells (HUVECs) by binding to
endothelial protein C receptor (EPCR) and signaling via
protease-activated receptors-1 (PAR-1) [13]. Therefore, it is
hypothesized that APC act as an ER stressor and elicit ER
stress. However, APC upregulation of GRP78, a marker of
ER stress, the impact of calcium release from the ER induced
by APC on EC apoptosis, and also APC inhibition of
LPS-induced apoptosis mediated by GSK-3β are issues that
remain to be clariﬁed.
In this study, the eﬀect of APC treatment on GRP78
protein expression was investigated and the relationship with
lipopolysaccharide-(LPS-) induced apoptosis was evaluated.
The speciﬁc inhibitor of calcium release from the ER, 8-(N,
N-diethylamino)-octyl-3, 4, 5-trimethoxybenzoate (TMB-
8), was used to investigate the eﬀect of calcium release from
ER induced by APC on LPS-induced apoptosis. Moreover,
GSK-3β protein expression following APC treatment was
analyzed and GSK-3β-siRNA was employed to assess its
role in the mechanism underlying the anti-apoptotic eﬀect
of APC. It was observed that APC-induced ER stress and
attenuatedLPS-inducedapoptosismediatedbyGSK-3β,thus
suggesting the existence of a novel antiapoptotic mechanism
utilized by HUVECs allowing adaptation to LPS challenge.
2.MaterialsandMethods
2.1. Reagents and Antibodies. HUVECs were obtained from
ScienCell Research Laboratories (San Diego, CA, USA).
RPMI 1640 medium, 10% fetal bovine serum (FBS), and
Opti-MEM were obtained from GIBCO (Grand Island, NY,
USA). APC, LPS, Annexin V-FITC, and propidium iodide
(PI) were obtained from Sigma (St. Louis, MO, USA). TMB-
8 was obtained from Aldrich Chemical Co. (Milwaukee,
WI, USA). The following antibodies were used for Western
blots: monoclonal mouse antibodies against human GRP78
(Bioworld Technology, Minneapolis, MN, USA), GSK-3β
(Santa Cruz Biotechnology, Santa Cruz, CA, USA), and
GAPDH (KangChen, Shanghai, China). Protein assay and
ECL kits were obtained from Santa Cruz Biotechnology
(Santa Cruz, CA, USA). Lipofectamine 2000 (11668-027)
was obtained from Invitrogen (Carlsbad, CA, USA). BCA
protein assay kit was obtained from Pierce Chemical Co.
(Rockford, IL, USA).
2.2. Cell Culture. HUVECs were cultured in RPMI 1640
medium supplemented with 10% FBS, 100μg/mL penicillin,
and 100 U/mL streptomycin, at 37◦Ci na5 %C O 2—95%
air-humidiﬁed incubator (Heraeus, Germany). Cells were
trypsinized and passaged weekly. The cells were then seeded
on 60mm dishes and treated experimentally after overnight
culture.
2.3. Small Interference RNA (siRNA) Transfection. Cells were
grown overnight in 12-well plates to a density of 3-4 × 104
viable cells per well and transfected with siRNA for GSK-3β
(Genepharma, Shanghai, China) using Lipofectamine 2000
transfection reagent according to the protocol provided by
the manufacturer. After 24h, media was exchanged and
the cells were treated with LPS for an additional 24h.
TransfectioneﬃciencyofGSK-3β-siRNAwasassessedbyRT-
PCR for GSK-3β mRNA and immunoblotting for GSK-3β
protein. APC treatment (150nM) was conducted for 0, 6, 12,
and24h.Finally,cellswereharvestedforapoptosisassaysand
Western blot analysis.
2.4. Apoptosis Assays. Approximately 2 × 105 cells/well of
HUVECs in 12-well plates at concentrations of 10ng/mL
LPS were incubated in an incubator for 24 hours, and subse-
quently treated with 150nM APC for 0, 6, 12, and 24h. Cells
were trypsinized and washed with PBS, then harvested by
centrifugation. The cells were resuspended in PBS, followed
by PI-Annexin V-FITC staining. Flow cytometric analysis of
PI-Annexin V-FITC staining was conducted according to the
instructionsprovidedbythemanufacturerforquantiﬁcation
of apoptosis. Results represent the mean of triplicate deter-
minations in which a minimum of 10,000 cells were assayed
for each determination.
2.5. Western Blot Analysis. Cells were grown in 100mm
dishes to a density of 5–7 × 105 viable cells per dish, and
t h e nw e r ep r e t r e a t e dw i t h1 0n g / m LL P Sf o r2 4hb e f o r et h e
addition of 150nM APC for 0, 6, 12, and 24h. Subsequently,
cells were trypsinized and washed with PBS, then harvested
by centrifugation for following experiments. At varying time
points during APC treatment, cells were lysed in Triton lysis
buﬀer (20mM Tris, pH 7.4, 137mM NaCl, 10% glycerol,
1% Triton X-100, 2mM EDTA, 1mM PMSF, 10mM NaF,
5mg/mL aprotinin, 20mM leupeptin, and 1mM sodium
orthovanadate) and centrifuged at 12,000g for 15min.
Protein concentrations were measured using the BCA assay.
Protein samples were resolved by SDS polyacrylamide gel
electrophoresis (SDS-PAGE), transferred to polyvinylidene
ﬂuoride (PVDF) membranes, and then blocked with 5%
skimmed milk powder containing 0.1% Tween-20. Blots
w e r et h e np r o b e da t4 ◦C overnight with relevant antibod-
ies, washed with TBST (TBS containing 0.1% Tween-20)
three times, and probed with the appropriate horseradish
peroxidase-conjugated secondary antibodies at room tem-
perature for 2h. The relative abundance of each protein was
determined by scanning densitometry using GAPDH as an
internal control. All immunoblots were visualized by ECL.
2.6. Statistical Analysis. At least three independent exper-
iments were conducted for each treatment. Comparisons
within groups were made using an appropriate Student’s t-
test. P<0.05 was considered statistically signiﬁcant.Mediators of Inﬂammation 3
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Figure 1: APC attenuated LPS-induced apoptosis in HUVECs. Flow cytometric analysis of cultured HUVECs continuously exposed to
10ng/mL LPS for 24h revealed a high percentage of apoptotic cells (a). Subsequently, LPS-stimulated HUVECs were treated with 150nM
APC for 0, 6, 12 and 24h ((a), (b), (c), and (d)). APC inhibition of cell apoptosis was detected following 6h exposure ((b), (e); P<0.05) and
then generally decreased. Flow cytometric analysis of PI-Annexin V-FITC staining revealed that 150nM APC treatment markedly attenuated
LPS-induced apoptosis in HUVECs.4 Mediators of Inﬂammation
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Figure 2: APC-induced GRP78 expression in the presence and absence of LPS stimulation. Following HUVEC treatment with 150nM APC
for 0, 6, 12, and 24h, upregulated GRP78 expression was initially detected at 6h by Western blot analysis (GRP78 (a), P<0.05), and then
generally decreased. After continuous exposure to 10ng/mL LPS for 24h, HUVECs were treated with 150nM APC for 0, 6, 12, and 24h.
Upregulated GRP78 expression was also detected at 6h by Western blot analysis (GRP78 (b), P<0.05), and then generally decreased. A
signiﬁcant diﬀerence in APC-induced GRP78 expression in the presence (b) and absence (a) of LPS stimulation was detected at 6h, which
indicated that 150nM APC plays a more signiﬁcant role in this eﬀect following LPS stimulation (P<0.05).
3. Results
3.1. APC Attenuation of LPS-Induced Apoptosis in HUVECs.
As an initial step to clarify the antiapoptotic mechanism of
APC, the eﬀect of APC treatment on HUVECs survival
following LPS stimulation was examined. Cells were contin-
uously exposed to 10ng/mL LPS for 24h and subsequently
treated with 150nM APC for 0, 6, 12 and 24h. It was
observedthatAPCinhibitedcellapoptosismarkedlyafter6h
of APC treatment. Flow cytometric analysis of PI-Annexin
V-FITC staining revealed that APC treatment markedly de-
creasedthenumberofapoptoticcells(P<0.05).Collectively,
these data show that 150nM APC treatment attenuated LPS-
induced apoptosis in HUVECs (Figure 1).
3.2. APC Induction of UPR in the ER. Evidence has been
obtained in previous studies that 150nM APC induces a
transient rise in calcium release from ER in HUVECs,
implying an ER disturbance evoked by APC [13]. To inves-
tigate ER stress induced by APC, the eﬀect of an ER-stress-
related protein, GRP78 on HUVECs was examined following
exposure for 0, 6, 12, 24h. APC treatment upregulated
GRP78 protein expression at 6h (Figure 2). Upregulated
GRP78 is responsible for the UPR in the ER. Therefore, these
data indicate that APC acts as an ER stressor and elicits the
UPR.
3.3.Calcium Inhibitor Did Not Alterthe AntiapoptoticEﬀectof
APC. The inhibitor of calcium release, TMB-8, was used to
investigate the inﬂuence of the transient rise of intracellular
calcium-inducedbyAPConHUVECapoptosis.Theeﬀective
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Figure 3: Calcium inhibition did not alter the antiapoptotic eﬀect
of APC. After exposure to 10ng/mL LPS for 24h, HUVECs were
treated with 150nM APC for 0, 6, 12, and 24h in the presence
or absence of 50μM TMB-8, an inhibitor of calcium release from
the ER. There was no signiﬁcant diﬀerence in the percentage of
apoptosis cells between the two groups, which was detected by ﬂow
cytometric analysis (APC versus APC + TMB-8, P>0.05).
TMB-8 dose for inhibition of calcium release from the ER
has been veriﬁed to be 50μM. Therefore LPS-pretreated
HUVECs were exposed to 150nM APC in the presence or
absence of TMB-8 (50μM) for 0, 6, 12, and 24h. Apoptosis
of HUVECs were examined by ﬂow cytometric analysis.
No signiﬁcant changes in apoptosis was observed in LPS-
pretreated HUVECs between the two groups (APC versus
APC + TMB-8, P>0.05) (Figure 3).Mediators of Inﬂammation 5
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Figure 4: Upregulation of GSK-3β expression following APC treatment and decreased antiapoptotic activity following GSK-3β-siRNA
transfectionofHUVECs.HUVECsexposedto10ng/mLLPSfor24h,weretreatedwith150nMAPCfor0,6,12,and24h.UpregulatedGSK-
3β expression was detected, peaking at 6h after APC treatment (a). Transfection of HUVECs with GSK-3β-siRNA decreased the abundance
of GSK-3β protein signiﬁcantly (b). Compared with normal HUVECs treated with 150nM APC, a signiﬁcant increase of the percentage
of apoptosis cells was found in HUVECs pretreated with GSK-3β-siRNA (GSK-3β versus GSK-3β-siRNA, P<0.05), indicating that the
antiapoptotic activity of APC was inhibited by GSK-3β-siRNA (c).
3.4. Upregulation of GSK-3β by APC and Reduction in Anti-
apoptotic Activity Following GSK-3β-siRNA Treatment. APC
treatment elicited a rise in GSK-3β expression, peaking after
6h APC treatment. The level of GSK-3β generally decreased
with prolonged APC treatment (Figure 4(a)). To further
substantiate the role of GSK-3β,G S K - 3 β-siRNA was used to
inhibit the expression of GSK-3β. HUVECs transfected by
GSK-3β-siRNA showed a substantial reduction in GSK-3β
mRNA compared to the control by RT-PCR analysis (GSK-
3β- s i R N Av e r s u sc o n t r o l ,P<0.05). Transfection of HUVEC
with GSK-3β-siRNA decreased the abundance of GSK-3β
protein signiﬁcantly (Figure 4(b)). Compared with normal
HUVECs treated with 150nM APC, a signiﬁcant increase
in the number apoptotic cells was detected in HUVECs
pretreatedwithGSK-3β-siRNA(Figure 4(c)),thusindicating
that antiapoptotic activity of APC was partially inhibited by
GSK-3β-siRNA.
4. Discussion
This study demonstrated that APC induces ER stress and
elicited the GSK-3β-mediated antiapoptotic eﬀect, thus
attenuating LPS-induced apoptosis. Further evidence of the
role of APC as an ER stressor was also obtained. A series of
intrinsic and extrinsic ER stressors have been reported, such
as hypoxia, ischemic, and reperfusion injury, nutrient depri-
vation, pH change, calcium depletion from the ER lumen,
inhibition of asparagine (N)-linked glycosylation, reduction
of disulﬁde bonds, and overexpression of some proteins [10–
12]. These ER stressors cause two types of characteristic
changes in the ER: upregulation of molecular chaperones
such as GRP78 and calcium release [13]. D¨ om¨ ot¨ or et
al. reported that HUVECs challenged with 150nM APC
responded with a transient elevation in intracellular calcium.
After ER calcium stores were depleted using thapsigargin
(TG), subsequent exposure of cells to APC did not evoke
an intracellular calcium signal, conﬁrming the ER as the
origin of APC-evoked calcium signals [13]. In this study,
it was demonstrated that treatment of cultured HUVECs
with 150nM APC elicited a rise in GRP78 expression in
parallel with the attenuation of apoptosis in HUVECs over
time (Figure 1). While GRP78 was upregulated at 6h, the
percentage of apoptotic HUVECs was markedly reduced at
the same time. While the level of GRP78 declined at 12h6 Mediators of Inﬂammation
and24h,thepercentageofapoptoticHUVECswasmarkedly
reduced at the same time. These observations conﬁrmed that
APC acts as an ER stressor and induces a UPR in the ER,
which in turn, plays an antiapoptotic role in LPS-stimulated
HUVECs.
ER is the main intracellular storage compartment for
calcium. The close physical contact of mitochondria and the
ER results in the mitochondria being exposed to more intra-
cellular calcium than the rest of cytosol when intracellular
calcium is released from the ER. Calcium overload of
mitochondria promotes permeabilization of the outer mito-
chondrial membrane and the release of several apoptogenic
factorsresulting in cell apoptosis [15, 16]. However, Deniaud
reported that ER stress agents and physiological stimuli
generated calcium ﬂux of the mitochondrial compartment,
but cell apoptosis or death was indeterminate. Histamine is a
typical ER stressor that induces a transient calcium increase
without cell death [17]. However, it is not known whether
the transient intracellular calcium elevation evoked by APC
causes calcium-induced mitochondrial apoptosis. In this
study, TMB-8, a speciﬁc inhibitor of calcium release from
the ER, was used to block calcium transfer from the ER to
the mitochondrion. As a result, LPS-induced apoptosis was
not attenuated, which implied that APC-evoked intracellular
calcium elevation did not cause calcium-induced mitochon-
drial apoptosis.
GSK-3β was initially described as a key component of
the glycogen metabolic pathway. GSK-3β is also a multifunc-
tional serine/threonine kinase, involved in the phosphoryla-
tion of transcription and translation factors as well as regu-
lation of the cell cycle and proliferation [18, 19]. ER stress
induces p53 phosphorylation by GSK-3β, which facilitates
nucleocytoplasmic export and degradation of p53 [14]. In
this study, APC treatment was shown to elicit upregulation
of GSK-3β in normal HUVECs. In GSK-3β-siRNA-treated
HUVECs, the expression of GSK-3β was inhibited, with a
subsequent decrease in the antiapoptotic eﬃciency of APC,
thus indicating that GSK-3β is an essential mediator of the
antiapoptotic eﬀect of APC.
In summary, this study demonstrated that APC-induced
ER stress in HUVECs and attenuated LPS-induced HUVEC
apoptosis mediated by GSK-3β.
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